Janssen-Ortho Inc., Canada clinical trials

A country office of Johnson & Johnson

The registry lists 22 studies whose lead sponsor is Janssen-Ortho Inc., Canada. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 20, 2016.

Studies

Recruiting first, then most recently updated. Showing 22 of 22. All Johnson & Johnson studies →

• A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.WithdrawnNCT00269971Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma PatientsNo longer availableNCT00799539

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01424930Phase 2

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early PsychosisCompletedNCT00246259Phase 4

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their MedicationTerminatedNCT00256997Phase 4

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney FunctionTerminatedNCT00718640Phase 2

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• Impact of Tolerability Issues on Chronic PainCompletedNCT01484301

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy VolunteersCompletedNCT01118702Phase 1

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking PantoprazoleCompletedNCT00378287Phase 1

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in AdultsCompletedNCT00246207Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma PatientsCompletedNCT00561743Phase 2

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder ChildrenCompletedNCT00304681Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With TriptansCompletedNCT00261469Phase 2

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement SurgeryCompletedNCT00269958Phase 2

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.CompletedNCT00553449Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.CompletedNCT00246233Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar DisorderCompletedNCT00246246Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.CompletedNCT00364260Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)CompletedNCT00261508Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of RisperdoneCompletedNCT00246272Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.CompletedNCT00364455Phase 3

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada

• An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive MethodCompletedNCT00653016Phase 4

  Sponsor listed in the registry: Janssen-Ortho Inc., Canada